kidney failure
Conditions
Interventions
A daily dose 7.5 g of Ninjinyoeito extract fine granules is orally administered twice a day before or between meals
Sponsors
OTA HIDETAKA
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Dialysis patients 2) Patients who are diagnosed as frail or pre-frail based on revised J-CHS criteria 3) Patients 65 years or older at the time of consent acquisition 4) Patients with SNAQ score of 14 or less 5) Patients who can understand the contents of informed consent form and can voluntarily sign the form
Exclusion criteria
Exclusion criteria: 1) Patients who have taken Kampo medicines within one month before the start of the study 2) Patients who started or changed the administration of psychotropic drugs, nootropics, antidepressants, mood stabilizers, psychostimulants, anxiolytics, or sleeping pills within 3 months before the start of the study 3) Patients with malignant tumor 4) Patients who have difficulty walking independently 5) Patients who the investigator determined difficult to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in SNAQ (Simplified Nutritional Appetite Questionnaire) score after 4,8,12 week of intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the parameters described below after 4,8,12 week of intervention : revised J-CHS criteria (body weight, grip strength, fatigue, walking speed, physical activity), MNA-SF(Mini Nutritional Assessment-Short Form), VI( Vitality Index), albumin level | — |
Contacts
Public ContactOTA HIDETAKA
Akita University
Outcome results
None listed